Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
Memorial Sloan Kettering-Rockefeller Outpatient Pavilion
2402
mi
from 98109
New York, NY
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
Memorial Sloan Kettering-Rockefeller Outpatient Pavilion
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
Virginia Mason Medical Center
1
mi
from 98109
Seattle, WA
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
Virginia Mason Medical Center
1
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Social Contextual Influences on Physical Activity
Social, Contextual, and Environmental Determinants of Physical Activity in Sedentary Minority Adults
Status: Enrolling
Updated:  2/19/2018
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Social Contextual Influences on Physical Activity
Social, Contextual, and Environmental Determinants of Physical Activity in Sedentary Minority Adults
Status: Enrolling
Updated: 2/19/2018
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer
A Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Patients With Castration-Resistant Prostate Cancer
Status: Enrolling
Updated:  2/19/2018
Urology Cancer Center, PC
1366
mi
from 98109
Omaha, NE
Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer
A Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Patients With Castration-Resistant Prostate Cancer
Status: Enrolling
Updated: 2/19/2018
Urology Cancer Center, PC
1366
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Smart Phone Application in Increasing Physical Activity in Breast Cancer Survivors
Facilitating Motivational Readiness and Adoption of Physical Activity by Breast Cancer Survivors With a Smart Phone Application
Status: Enrolling
Updated:  2/19/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
2373
mi
from 98109
Philadelphia, PA
Smart Phone Application in Increasing Physical Activity in Breast Cancer Survivors
Facilitating Motivational Readiness and Adoption of Physical Activity by Breast Cancer Survivors With a Smart Phone Application
Status: Enrolling
Updated: 2/19/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated:  2/20/2018
Johns Hopkins Hospital
2329
mi
from 98109
Baltimore, MD
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated: 2/20/2018
Johns Hopkins Hospital
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated:  2/20/2018
Memoral Sloan Kettering Cancer Center
2377
mi
from 98109
Basking Ridge, NJ
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated: 2/20/2018
Memoral Sloan Kettering Cancer Center
2377
mi
from 98109
Basking Ridge, NJ
Click here to add this to my saved trials
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated:  2/20/2018
Memorial Sloan-Kettering Cancer Center @ Suffolk
2431
mi
from 98109
Commack, NY
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated: 2/20/2018
Memorial Sloan-Kettering Cancer Center @ Suffolk
2431
mi
from 98109
Commack, NY
Click here to add this to my saved trials
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated:  2/20/2018
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated: 2/20/2018
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated:  2/20/2018
M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated: 2/20/2018
M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Sexual Behavior in Head and Neck Cancer Patients
Sexual Behavior in Head and Neck Cancer Patients
Status: Enrolling
Updated:  2/20/2018
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Sexual Behavior in Head and Neck Cancer Patients
Sexual Behavior in Head and Neck Cancer Patients
Status: Enrolling
Updated: 2/20/2018
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Longitudinal Study of Symptoms in Colorectal Cancer
Prospective Study of Symptoms Related to Oxaliplatin-based Regimens in the Treatment of Colorectal Cancer
Status: Enrolling
Updated:  2/20/2018
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Longitudinal Study of Symptoms in Colorectal Cancer
Prospective Study of Symptoms Related to Oxaliplatin-based Regimens in the Treatment of Colorectal Cancer
Status: Enrolling
Updated: 2/20/2018
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer
A Phase II Open-labeled, Prospective Study to Determine the Efficacy of Preoperative Chemoradiation With Oxaliplatin/5-FU in Locally Advanced Rectal Cancer Followed by Total Mesorectal Excision and FOLFOX6
Status: Enrolling
Updated:  2/20/2018
Beth Israel Medical Center - Philipps Ambulatory Care Center
2402
mi
from 98109
New York, NY
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer
A Phase II Open-labeled, Prospective Study to Determine the Efficacy of Preoperative Chemoradiation With Oxaliplatin/5-FU in Locally Advanced Rectal Cancer Followed by Total Mesorectal Excision and FOLFOX6
Status: Enrolling
Updated: 2/20/2018
Beth Israel Medical Center - Philipps Ambulatory Care Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer
A Phase II Open-labeled, Prospective Study to Determine the Efficacy of Preoperative Chemoradiation With Oxaliplatin/5-FU in Locally Advanced Rectal Cancer Followed by Total Mesorectal Excision and FOLFOX6
Status: Enrolling
Updated:  2/20/2018
St. Luke's-Roosevelt Hospital Center - Roosevelt Division
2401
mi
from 98109
New York, NY
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer
A Phase II Open-labeled, Prospective Study to Determine the Efficacy of Preoperative Chemoradiation With Oxaliplatin/5-FU in Locally Advanced Rectal Cancer Followed by Total Mesorectal Excision and FOLFOX6
Status: Enrolling
Updated: 2/20/2018
St. Luke's-Roosevelt Hospital Center - Roosevelt Division
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer
Status: Enrolling
Updated:  2/20/2018
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer
Status: Enrolling
Updated: 2/20/2018
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer
Status: Enrolling
Updated:  2/20/2018
Morristown Memorial Hospital, Women's Cancer Center
2399
mi
from 98109
Morristown, NJ
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer
Status: Enrolling
Updated: 2/20/2018
Morristown Memorial Hospital, Women's Cancer Center
2399
mi
from 98109
Morristown, NJ
Click here to add this to my saved trials
Symptom Inventory for Gastrointestinal Stromal Tumors
Symptom Burden in Patients With Gastrointestinal Stromal Tumors (GISTs)
Status: Enrolling
Updated:  2/20/2018
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Symptom Inventory for Gastrointestinal Stromal Tumors
Symptom Burden in Patients With Gastrointestinal Stromal Tumors (GISTs)
Status: Enrolling
Updated: 2/20/2018
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  2/20/2018
St John's Mercy Medical Center
1709
mi
from 98109
Saint Louis, MO
Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 2/20/2018
St John's Mercy Medical Center
1709
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
A Randomized Phase 2 Trial of AEZS-108 in Chemotherapy Refractory Triple Negative, LHRH-positive Metastatic Breast Cancer.
Status: Enrolling
Updated:  2/20/2018
University of Miami
2730
mi
from 98109
Miami, FL
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
A Randomized Phase 2 Trial of AEZS-108 in Chemotherapy Refractory Triple Negative, LHRH-positive Metastatic Breast Cancer.
Status: Enrolling
Updated: 2/20/2018
University of Miami
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
A Randomized Phase 2 Trial of AEZS-108 in Chemotherapy Refractory Triple Negative, LHRH-positive Metastatic Breast Cancer.
Status: Enrolling
Updated:  2/20/2018
Universitäts-Frauenklinik
5025
mi
from 98109
Göttingen,
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
A Randomized Phase 2 Trial of AEZS-108 in Chemotherapy Refractory Triple Negative, LHRH-positive Metastatic Breast Cancer.
Status: Enrolling
Updated: 2/20/2018
Universitäts-Frauenklinik
5025
mi
from 98109
Göttingen,
Click here to add this to my saved trials
Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer
Pilot Study of Eovist (Gadoxetate) Enhanced MRI for the Detection of Prostate Cancer
Status: Enrolling
Updated:  2/20/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer
Pilot Study of Eovist (Gadoxetate) Enhanced MRI for the Detection of Prostate Cancer
Status: Enrolling
Updated: 2/20/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System
Status: Enrolling
Updated:  2/20/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
2373
mi
from 98109
Philadelphia, PA
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System
Status: Enrolling
Updated: 2/20/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System
Status: Enrolling
Updated:  2/20/2018
Reading Hospital
2324
mi
from 98109
Reading, PA
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System
Status: Enrolling
Updated: 2/20/2018
Reading Hospital
2324
mi
from 98109
Reading, PA
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
1221
mi
from 98109
Tucson, AZ
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
1221
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
965
mi
from 98109
Pomona, CA
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
965
mi
from 98109
Pomona, CA
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
2725
mi
from 98109
Aventura, FL
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
2725
mi
from 98109
Aventura, FL
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
2720
mi
from 98109
Hollywood, FL
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
2720
mi
from 98109
Hollywood, FL
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
2543
mi
from 98109
Lakeland, FL
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
2543
mi
from 98109
Lakeland, FL
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
2527
mi
from 98109
Ormond Beach, FL
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
2527
mi
from 98109
Ormond Beach, FL
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
2188
mi
from 98109
Lawrenceville, GA
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
2188
mi
from 98109
Lawrenceville, GA
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
1634
mi
from 98109
Galesburg, IL
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
1634
mi
from 98109
Galesburg, IL
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
1935
mi
from 98109
New Albany, IN
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
1935
mi
from 98109
New Albany, IN
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
1793
mi
from 98109
Grand Rapids, MI
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
1793
mi
from 98109
Grand Rapids, MI
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
1816
mi
from 98109
Kalamazoo, MI
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
1816
mi
from 98109
Kalamazoo, MI
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
667
mi
from 98109
Billings, MT
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
667
mi
from 98109
Billings, MT
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
1182
mi
from 98109
Albuquerque, NM
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
1182
mi
from 98109
Albuquerque, NM
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
2352
mi
from 98109
Albany, NY
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
2352
mi
from 98109
Albany, NY
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
2402
mi
from 98109
Armonk, NY
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
2402
mi
from 98109
Armonk, NY
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
2230
mi
from 98109
Greenville, SC
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
2230
mi
from 98109
Greenville, SC
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
2083
mi
from 98109
Chattanooga, TN
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
2083
mi
from 98109
Chattanooga, TN
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
1971
mi
from 98109
Nashville, TN
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
1680
mi
from 98109
Dallas, TX
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
1680
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
1763
mi
from 98109
Tyler, TX
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
1763
mi
from 98109
Tyler, TX
Click here to add this to my saved trials
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
The Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Metastatic Breast Cancer Patients Previously Responsive to Hormonal Therapy: A Phase II Trial
Status: Enrolling
Updated:  2/20/2018
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
The Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Metastatic Breast Cancer Patients Previously Responsive to Hormonal Therapy: A Phase II Trial
Status: Enrolling
Updated: 2/20/2018
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer
Phase Ib/II Study to Determine the Recommended Dose, Safety, and Preliminary Efficacy of Belinostat When Used in Combination With Carboplatin, Paclitaxel, and Bevacizumab in Patients With Untreated Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  2/21/2018
Holy Cross Hospital
2717
mi
from 98109
Fort Lauderdale, FL
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer
Phase Ib/II Study to Determine the Recommended Dose, Safety, and Preliminary Efficacy of Belinostat When Used in Combination With Carboplatin, Paclitaxel, and Bevacizumab in Patients With Untreated Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 2/21/2018
Holy Cross Hospital
2717
mi
from 98109
Fort Lauderdale, FL
Click here to add this to my saved trials
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
Prospective Evaluation of Low-dose Irinotecan and Cyberknife® Stereotactic Body Radiotherapy in the Treatment of Patients With Colorectal Cancer and Limited Liver Metastasis
Status: Enrolling
Updated:  2/21/2018
Advocate Lutheran General Hospital
1718
mi
from 98109
Park Ridge, IL
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
Prospective Evaluation of Low-dose Irinotecan and Cyberknife® Stereotactic Body Radiotherapy in the Treatment of Patients With Colorectal Cancer and Limited Liver Metastasis
Status: Enrolling
Updated: 2/21/2018
Advocate Lutheran General Hospital
1718
mi
from 98109
Park Ridge, IL
Click here to add this to my saved trials
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated:  2/21/2018
Indiana University Melvin and Bren Simon Cancer Center
1867
mi
from 98109
Indianapolis, IN
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated: 2/21/2018
Indiana University Melvin and Bren Simon Cancer Center
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated:  2/21/2018
Sidney and Lois Eskenazi Hospital
1867
mi
from 98109
Indianapolis, IN
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated: 2/21/2018
Sidney and Lois Eskenazi Hospital
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Mayo Clinic Scottsdale
1113
mi
from 98109
Scottsdale, AZ
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Mayo Clinic Scottsdale
1113
mi
from 98109
Scottsdale, AZ
Click here to add this to my saved trials